TFIPS
Towarzystwo Funduszy Inwestycyjnych PZU SA Portfolio holdings
AUM
$356M
This Quarter Return
-3.07%
1 Year Return
+18.65%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$83.8M
AUM Growth
+$83.8M
(-1%)
Cap. Flow
+$2.81M
Cap. Flow
% of AUM
3.35%
Top 10 Holdings %
Top 10 Hldgs %
55.07%
Holding
397
New
23
Increased
48
Reduced
42
Closed
8
Top Buys
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
$7.3M |
| 2 |
American Tower
AMT
|
$4.63M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$1.12M |
| 4 |
Moderna
MRNA
|
$212K |
| 5 |
NVIDIA
NVDA
|
$204K |
Top Sells
| 1 |
Alibaba
BABA
|
$4.89M |
| 2 |
Kinross Gold
KGC
|
$3.89M |
| 3 |
Cigna
CI
|
$2.47M |
| 4 |
GE Aerospace
GE
|
$361K |
| 5 |
Newmont
NEM
|
$326K |
Sector Composition
| 1 | Healthcare | 34.31% |
| 2 | Technology | 30.11% |
| 3 | Materials | 11.19% |
| 4 | Communication Services | 7.91% |
| 5 | Real Estate | 6.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Boston Scientific
BSX
$156B
| $617K | 0.74% |
14,229
+1,410
| +11% | +$61.2K |
|
27
Medtronic
MDT
$119B
| $599K | 0.71% |
4,775
+850
| +22% | +$107K |
|
28
HCA Healthcare
HCA
$94.5B
| $563K | 0.67% |
2,319
+210
| +10% | +$51K |
|
29
Gilead Sciences
GILD
$140B
| $491K | 0.59% |
7,027
+760
| +12% | +$53.1K |
|
30
Vertex Pharmaceuticals
VRTX
$100B
| $465K | 0.56% |
2,566
-75
| -3% | -$13.6K |
|
31
Elevance Health
ELV
$71.8B
| $456K | 0.54% |
1,223
-75
| -6% | -$28K |
|
|
32
Cigna
CI
$80.3B
| $452K | 0.54% |
2,256
-12,330
| -85% | -$2.47M |
|
|
33
NVIDIA
NVDA
$4.24T
| $379K | 0.45% |
1,830
+985
| +117% | +$204K |
|
34
Meta Platforms (Facebook)
META
$1.86T
| $355K | 0.42% |
1,046
+75
| +8% | +$25.5K |
|
35
Becton Dickinson
BDX
$55.3B
| $354K | 0.42% |
1,440
-40
| -3% | -$9.83K |
|
36
Zimmer Biomet
ZBH
$21B
| $333K | 0.4% |
2,274
-70
| -3% | -$10.2K |
|
37
Illumina
ILMN
$15.8B
| $304K | 0.36% |
750
-30
| -4% | -$12.2K |
|
38
Tesla
TSLA
$1.08T
| $279K | 0.33% |
360
+45
| +14% | +$34.9K |
|
39
IQVIA
IQV
$32.4B
| $271K | 0.32% |
1,132
| – | – |
|
40
Idexx Laboratories
IDXX
$51.8B
| $261K | 0.31% |
420
-20
| -5% | -$12.4K |
|
41
Agilent Technologies
A
$35.7B
| $261K | 0.31% |
1,655
-115
| -6% | -$18.1K |
|
42
Align Technology
ALGN
$10.3B
| $260K | 0.31% |
391
| – | – |
|
43
Stryker
SYK
$150B
| $253K | 0.3% |
960
-50
| -5% | -$13.2K |
|
|
44
Alphabet (Google) Class C
GOOG
$2.58T
| $243K | 0.29% |
91
+30
| +49% | +$80K |
|
45
Baxter International
BAX
$12.7B
| $240K | 0.29% |
2,988
| – | – |
|
46
Jazz Pharmaceuticals
JAZZ
$7.75B
| $240K | 0.29% |
1,845
-160
| -8% | -$20.8K |
|
47
Hologic
HOLX
$14.9B
| $240K | 0.29% |
3,254
-220
| -6% | -$16.2K |
|
48
JPMorgan Chase
JPM
$829B
| $217K | 0.26% |
1,324
| – | – |
|
49
Veeva Systems
VEEV
$44B
| $208K | 0.25% |
721
| – | – |
|
50
Avantor
AVTR
$9.18B
| $206K | 0.25% |
5,040
-360
| -7% | -$14.7K |
|